Search the GHTC website
October 1, 2013

What’s ahead on the Hill: An update on the government shutdown and global health R&D programs

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about how the government shutdown and budget negotiations in Congress will impact global health research and development (R&D) programs across the federal government.

February 27, 2013

Investing in the future: GHTC congressional briefing highlights compelling benefits of global health research

“I’d be careful not to break something that would be hard to put back together,” Alan Magill—director of Malaria at the Bill and Melinda Gates Foundation—said this week at the GHTC’s annual congressional briefing.